• Latest Posts

ADC Approval Buoys Spirits in Cancer Treatment Space

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

In Depth 9 Apr 2018

Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?

MSD Offers €464M to Buy German Biotech Fighting Cancer with RNA

German Biotech Unveils Positive Phase II Results for Alzheimer’s


Berlin Biotech Advances its Cancer Drug in a New Trial with Keytruda

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

UPDATE: Sanofi defeated in the Race to acquire Medivation

And now, Immuno-oncology gets EMA’s pre-approval for Lung Cancer

How will the UK’s Potential Exit from the EU Affect the Biotech Industry?

New Discovery unites Australia, Germany and UK Against Blood Cancers